Hong Kong-based COVID-19 testing firm Prenetics Ltd's shares fell 4.4% to $7.45 in their Nasdaq debut on Wednesday, following its merger with a U.S.-listed blank-check firm.
A PCR test detects the actual genetic material of the virus and involves a step that amplifies the presence of any material ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback